SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-24-000211
Filing Date
2024-05-23
Accepted
2024-05-23 09:31:01
Documents
17
Period of Report
2024-05-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rgbp052224form8k.htm   iXBRL 8-K 22568
2 EXHIBIT 3(I) ex3_i.htm EX-3 3412
3 GRAPHIC image_001.jpg GRAPHIC 109661
4 GRAPHIC image_002.jpg GRAPHIC 81444
5 GRAPHIC image_003.jpg GRAPHIC 58388
  Complete submission text file 0001607062-24-000211.txt   542440

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rgbp-20240520.xsd EX-101.SCH 3254
7 XBRL LABEL FILE rgbp-20240520_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE rgbp-20240520_pre.xml EX-101.PRE 22377
20 EXTRACTED XBRL INSTANCE DOCUMENT rgbp052224form8k_htm.xml XML 3797
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-191725 | Film No.: 24975410
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)